NightHawk Biosciences (NHWK)

NightHawk Biosciences (NHWK) Financial Statements


NightHawk Biosciences Financial Overview

NightHawk Biosciences's market cap is currently ―. The company's EPS TTM is $-2.003; its P/E ratio is -0.17; NightHawk Biosciences is scheduled to report earnings on March 29, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 657.78K$ 765.90K$ 79.92K$ 5.98M$ 50.98K
Gross Profit$ 1.37M$ 388.26K$ 295.26K$ -381.79K-
EBIT$ -14.34M$ -13.03M$ -15.84M$ -12.62M$ -9.92M
EBITDA$ -12.47M$ -11.24M$ -15.47M$ -11.73M$ -9.35M
Net Income Common Stockholders$ -13.89M$ -12.78M$ -12.15M$ -13.01M$ -10.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.56M$ 28.64M$ 44.27M$ 57.45M$ 69.95M
Total Assets$ 80.18M$ 91.52M$ 104.40M$ 120.16M$ 131.85M
Total Debt$ 11.24M$ 9.10M$ 9.39M$ 8.59M$ 2.28M
Net Debt$ -7.32M$ -19.54M$ -34.88M$ -48.86M$ -67.67M
Total Liabilities$ 33.11M$ 31.18M$ 31.96M$ 37.04M$ 36.47M
Stockholders Equity$ 48.76M$ 61.94M$ 73.92M$ 84.47M$ 96.64M
Cash Flow-
Free Cash Flow$ -7.50M$ -15.39M$ -8.30M$ -12.35M$ 6.53M
Operating Cash Flow$ -8.28M$ -13.77M$ -7.84M$ 3.57M$ 8.79M
Investing Cash Flow$ 8.84M$ 13.49M$ 7.37M$ -148.36K$ -13.03M
Financing Cash Flow$ -2.62M$ -298.52K$ -4.76M$ -34.53K$ -55.95K
Currency in USD

NightHawk Biosciences Earnings and Revenue History

NightHawk Biosciences Debt to Assets

NightHawk Biosciences Cash Flow

NightHawk Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis